Factive gemifloxacin quinolone antibiotic regulatory update

The FDA's Anti-Infective Drugs Advisory Committee recommended approval of Factive to treat mild to moderate community-acquired pneumonia (CAP) and to treat acute exacerbation of chronic bronchitis. La...